14
Participants
Start Date
February 16, 2022
Primary Completion Date
December 31, 2022
Study Completion Date
February 28, 2023
BrightGo cognitive training
Training on the BrightGo experimental device in the home
Standard of Care medication for early Alzheimer's Disease
Participant takes 10 mg of Aricept daily or wears an Exelon 9.5 mg patch and is stable on one of these medications that were prescribed for diagnostic of early Alzheimer's Disease
RECRUITING
Rutgers, The State University of New Jersey, New Brunswick
RECRUITING
Bright Cloud Int'l Corp, North Brunswick
Lead Sponsor
National Institute on Aging (NIA)
NIH
Rutgers, The State University of New Jersey
OTHER
Bright Cloud International Corp
INDUSTRY